| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.82B | +7.3% |
| Cost of Revenue | $3.04B | +10.8% |
| Gross Profit | $776.0M | -4.3% |
| R&D Expense | $38.0M | +5.6% |
| SG&A Expense | $340.0M | +6.3% |
| Interest Expense | $76.0M | +58.3% |
| Pre-tax Income | $338.0M | -21.4% |
| Income Tax | $80.0M | -24.5% |
| Net Income | $258.0M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $38.0M | -76.8% |
| Accounts Receivable | $348.0M | +10.1% |
| Inventory | $722.0M | +23.8% |
| Current Assets | $1.17B | +6.1% |
| Total Assets | $4.93B | +2.4% |
| Current Liabilities | $496.0M | +2.5% |
| Long-term Debt | $2.09B | -1.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $219.0M | -29.4% |
| Capital Expenditures | $128.0M | -9.2% |
| Investing Cash Flow | -$128.0M | +9.2% |
| Financing Cash Flow | -$217.0M | +31.5% |
| Free Cash Flow | $91.0M | -46.2% |
| -20.4% |
| EPS (Basic) | $1.23 | -20.1% |
| EPS (Diluted) | $1.23 | -20.1% |
| Total Liabilities |
| $3.06B |
| +0.2% |
| Stockholders' Equity | $1.87B | +6.4% |